期刊
JOURNAL OF DRUG TARGETING
卷 19, 期 8, 页码 690-700出版社
INFORMA HEALTHCARE
DOI: 10.3109/1061186X.2010.547585
关键词
Polymer-coated virus; vascular targeting; inflammation; cancer
资金
- Algerian Government
- Biotechnology and Biological Sciences Research Council [BBS/B/03599] Funding Source: researchfish
- Cancer Research UK [11339] Funding Source: researchfish
- Medical Research Council [G0700166] Funding Source: researchfish
- MRC [G0700166] Funding Source: UKRI
Background: E-selectin is an attractive endothelial cell surface marker in inflammation and cancer. Purpose: We sought to investigate retargeting of adenovirus via E-selectin as a viable pathway of infection in tumor necrosis factor-a (TNF-alpha)-activated human umbilical vein endothelial cells (HUVECs). Methods: E1, E3-deleted Ad5 expressing cytomegalovirus immediate-early (CMV IE) promoter-driven luciferase (Adluc) was coated with an amino-reactive multivalent hydrophilic polymer based on poly [N-(2-hydroxypropyl) methacrylamide] to generate pHPMA-adenovirus (pcAdluc). This was then retargeted by covalent attachment of a mouse antihuman E-selectin monoclonal antibody (MHES mAb), purified from the H18/7 hybridoma cell line (MHESpcAdluc). Results: MHESpcAdluc was efficiently taken up into HUVECs, generating a high level of transduction in TNF-alpha-treated E-selectin positive cells but not in untreated receptor-negative cells. Specific retargeting of MHESpcAdluc was demonstrated through reduced transduction of stimulated HUVEC when incubated in the presence of free E-selectin antibodies. Discussion and conclusion: Our results suggest that E-selectin could be a valuable target for gene transfer strategies internalizing polymer-coated modified adenovirus particles through a viable receptor-mediated endocytosis pathway, generating adequate levels of transgene expression per virus genome copy without compromising the specific activity of the parental virus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据